News
$Citius Pharmaceuticals (CTXR.US)$ Reuters
Just
Citius Pharmaceuticals Receives FDA Approval for Lymphir™ (Denileukin Diftitox-Cxdl) Immunotherapy for the Treatment of Adults With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Just
Citius Pharmaceuticals Receives FDA Approval for Lymphir™ (Denileukin Diftitox-Cxdl) Immunotherapy for the Treatment of Adults With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
萬軍無兵策天鳳 : Is this early? I don't understand the difference with PDUFA 13
Trytosaveabit OP 萬軍無兵策天鳳 : Yes it appears the decision came early.
萬軍無兵策天鳳 : There is no amount![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Trytosaveabit OP 萬軍無兵策天鳳 : Amount of what?